Skip to main content
Top
Published in: Reactions Weekly 1/2011

01-07-2011 | Case report

Muromonab-CD3

Fever, chills and diarrhoea in a paediatric renal transplant recipient: case report

Published in: Reactions Weekly | Issue 1/2011

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literature
1.
go back to reference Hori T, Nguyen JH, Uemoto S.Muromonab-CD3 for the successful treatment of early chronic rejection after pediatric liver transplantation: Report of a case. Surgery Today - The Japanese Journal of Surgery 41: 585-590, No. 4, Apr 2011. Available from: URL: http://dx.doi.org/10.1007/s00595-010-4309-x - Japan Hori T, Nguyen JH, Uemoto S.Muromonab-CD3 for the successful treatment of early chronic rejection after pediatric liver transplantation: Report of a case. Surgery Today - The Japanese Journal of Surgery 41: 585-590, No. 4, Apr 2011. Available from: URL: http://​dx.​doi.​org/​10.​1007/​s00595-010-4309-x - Japan
Metadata
Title
Muromonab-CD3
Fever, chills and diarrhoea in a paediatric renal transplant recipient: case report
Publication date
01-07-2011
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2011
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113620-00085

Other articles of this Issue 1/2011

Reactions Weekly 1/2011 Go to the issue

Case report

Iodine-131

Case report

Metformin

Case report

Artesunate

Case report

Tretinoin